Concomitant Renal and Urinary Bladder Allograft Transplantation

StatusRecruiting
PhaseEarly Phase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Aug 2026 → Aug 2027
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 2026 to Aug 2027
    • Study completion pushed from Aug 2026 to Sep 2027
    • Eligibility criteria expanded, about 34 words
  2. Primary and study completion dates: Jan 2026 to Aug 2026v10
  3. Site contacts updated at 1 of 2 sitesv9
  4. Study Status, Referencesv8
  5. Primary and study completion dates: Jan 1, 2026 to Jan 2026v7
Show 5 earlier versionsHide 5 earlier versions
  1. Re-verified, no change to tracked fieldsv6
  2. Start date changed from estimate of May 15, 2021 to Jun 1, 2021v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    v4
  4. Start date: Feb 15, 2021 to May 15, 2021v3
  5. Start date: Jan 1, 2021 to Feb 15, 2021v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,024 trials monitored
See 128 trials at risk
Chronic Kidney Disease
1,423 trials monitored
See 70 trials at risk
The purpose of this study is to establish if concomitant renal and vascularized urinary bladder allograft transplantation is feasible.
Trial Details
NCT Number NCT04626167
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Chronic Kidney Diseases, Bladder Dysfunction, Bladder Absence, Posterior Urethral Valve, Neurogenic Bladder, Bladder Exstrophy, Bladder Outlet Obstruction, Failure, Kidney +1 more
Related terms Bladder Exstrophy, Renal Insufficiency, Renal Insufficiency, Chronic, Urinary Bladder Neck Obstruction, Urinary Bladder, Neurogenic
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov